IMPACT – the introduction of mycotic prophylaxis at cystectomy trial.
Phase 1
Recruiting
- Conditions
- Fungal infectionTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- CTIS2023-506226-36-00
- Lead Sponsor
- Rigshospitalet
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 484
Inclusion Criteria
Patients > 18 years, Willingness to participate in the study and the ability to understand and sign an informed consent in Danish, Indication for performing cystectomy, The urinary diversion is limited to the ileal conduit
Exclusion Criteria
Patients with contraindications to Fluconazole. This includes allergies and treatment with non-pausable medication that in combination is contraindicated, Patients in active treatment for mycotic infections
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method